Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
British Journal of Clinical Pharmacology|June 7, 2022
Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipientsTom C Zwart, Erik Metscher, Paul J M van der Boog, et al.
Clinical Pharmacology and Therapeutics|October 9, 2019
Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical PharmacogeneticsMaaike van der Lee, William G Allard, Sander Bollen, et al.
Human Mutation|January 4, 2017
Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio SequencingHenk P J Buermans, Rolf H A M Vossen, Seyed Yahya Anvar, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2018
Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriersCarin A T C Lunenburg, Linda M Henricks, Eva Dreussi, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2023
Physiologically-based pharmacokinetic modeling of quinidine to establish a CYP3A4, P-gp, and CYP2D6 drug-drug-gene interaction networkDenise Feick, Simeon Rüdesheim, Fatima Zahra Marok, et al.
Clinical Pharmacology and Therapeutics|April 22, 2025
Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into AccountInger Johansson, Emmanouella M Xanthopoulou, Yitian Zhou, et al.
Clinical and Translational Science|October 25, 2019
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working GroupKelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, et al.
Clinical Pharmacokinetics|October 11, 2021
Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic StudyDirk Jan A R Moes, David J van Westerloo, Sandra M Arend, et al.
Pharmacogenetics and Genomics|April 22, 2017
Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinomaMaría Apellániz-Ruiz, Meta H Diekstra, Juan M Roldán, et al.
European Journal of Cancer (Oxford, England : 1990)|October 21, 2017
Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinibMichiel C Verboom, Jacqueline S L Kloth, Jesse J Swen, et al.
Pageof 15